ICBs in dispute with provider over ‘ticking timebomb’ drug costs

Achieving weight loss with orlistat

Multiple NHS commissioners are embroiled in a legal row with a private company they say is “intensively” marketing its online weight-loss drugs service, which could cost them hundreds of millions of pounds a year.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Already a subscriber? Sign into your account here